Friday, July 10, 2026

pharma · Prostate cancer

Curium Pharma

Curium Romania S.R.L is a pharma organization headquartered in EU. Primary therapeutic focus areas include Prostate cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this en

Boston, USA HQ
2017 Founded
2,181 Employees
EMA registrant Type
Company details
Status
Public
HQ
Boston, USA
Founded
2017
Employees
2,181
Programs
3
Drugs
0
Patents
0
Clinical program

Prostavue

Phase 3 · small molecule · Prostate cancer

Prostavue for Prostate cancer is a Phase 3 program (small_molecule) at Curium Romania S.R.L. with 1 ClinicalTrials.gov record(s).

← All Curium Romania S.R.L. projects Phase 3 small molecule active

Internal code IASON FC303

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Curium Romania S.R.L.
Phase
Phase 3
Modality
small_molecule
Indication
Prostate cancer
Status
active
Trials
1

Clinical trials